Daifuku
Koji Daifuku, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090233207 | PYRAZOLOTRIAZOLE COMPOUND AND ELECTROPHOTOGRAPHIC TONER - A compound represented by Formula (X-1) is disclosed. | 09-17-2009 |
| 20090233208 | COPPER COMPLEX COMPOUND AND ELECTROPHOTOGRAPHIC TONER CONTAINING THE SAME - A copper complex compound represented by Formula (1) is disclosed. | 09-17-2009 |
| 20090233209 | ELECTROPHOTOGRAPHIC TONER - An electrophotographic toner is disclosed. The toner contains a compound of Formula X-1 and a copper complex compound represented by the following Formula (1), which are defined detain in the specification. | 09-17-2009 |
| 20110152556 | COPPER COMPLEX COMPOUND AND ELECTROPHOTOGRAPHIC TONER CONTAINING THE SAME - A copper complex compound represented by Formula (1) is disclosed. | 06-23-2011 |
| 20110300481 | PYRAZOLOTRIAZOLE COMPOUND AND ELECTROPHOTOGRAPHIC TONER - A compound represented by Formula (X-1) is disclosed. | 12-08-2011 |
Makoto Daifuku, Nishikamo-Gun JP
| Patent application number | Description | Published |
|---|---|---|
| 20140170490 | LITHIUM SECONDARY BATTERY NEGATIVE ELECTRODE AND METHOD FOR MANUFACTURING THE SAME - Provided is a negative electrode having a new structure for realizing a lithium secondary battery having increased charging/discharging capacities and a battery capacity that is reduced less due to repeated charging/discharging. The negative electrode for a lithium secondary battery includes a current collector substrate; a carbon nanochips layer including graphene sheets grown to incline in irregular directions independently from the current collector substrate; and a silicon thin film layer on the carbon nanochips layer, in which gaps among the carbon nanochips are formed between the silicon thin film layer and the current collector substrate. The Raman spectrum of graphite forming the carbon nanochips layer has a g/d ratio of 0.30 to 0.80, both inclusive, and the crystallinity level of the graphite is lower than that of graphite forming carbon nanowalls. The carbon nanochips layer can be formed by a plasma CVD method using a gaseous mixture of methane and hydrogen, for example. | 06-19-2014 |
Makoto Daifuku, Miyoshi-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20150037675 | NEGATIVE ELECTRODE MATERIAL FOR LITHIUM SECONDARY BATTERY AND METHOD FOR MANUFACTURING THE SAME - To provide a high-capacity lithium secondary battery at a low price that attains an increased reversibility of charge and discharge, by using a new negative electrode material different from the existing negative electrode materials, and to provide a lithium secondary battery that can use an existing electrolyte at a small risk of ignition or overheating. | 02-05-2015 |
Richard Daifuku, Mercer Island, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080249097 | PRODRUGS OF HETEROARYL COMPOUNDS - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents. | 10-09-2008 |
| 20090192099 | PRODRUGS OF HETEROARYL COMPOUNDS - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents. | 07-30-2009 |
| 20090209505 | PRODRUGS OF HETEROARYL COMPOUNDS - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents. | 08-20-2009 |
| 20100279968 | Mutagenic Nucleoside Analogs for the Treatment of Viral Disease - The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs. | 11-04-2010 |
| 20110224434 | Prodrugs of Heteroaryl Compounds - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents. | 09-15-2011 |
| 20140024612 | FLUORINATED PYRIMIDINE ANALOGS AND METHODS OF USE THEREOF - Fluorinated pyrimidine analog compounds, compositions that include the fluorinated pyrimidine analog compounds, methods for making the fluorinated pyrimidine analog compounds, and methods for inhibiting DNA methyltransferase, treating solid tumors, and treating hematologic cancers by administering the fluorinated pyrimidine analog compounds. | 01-23-2014 |